Cryogatt, a leading innovator in cryogenic RFID technology, in collaboration with its global distributor and partner, Planer Ltd, showcased advanced traceability solutions at the 40th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) in Amsterdam. The event brought together global experts in reproductive medicine, providing a platform for Cryogatt and Planer to demonstrate how their combined expertise can revolutionize cryogenic storage and management.

 

ESHRE 2024 offered a unique opportunity for Cryogatt to engage with leading researchers, clinicians, and industry professionals. Attendees had the chance to learn about the latest advancements in cryogenic storage and explore how Cryogatt’s system can enhance efficiency, accuracy, and safety in laboratories and clinics.

 

Cryogatt’s RFID-based solution offers unparalleled benefits, including:

• Real-time inventory management: Precise tracking of cryogenic samples for optimal utilization and security.
• Enhanced sample traceability: Comprehensive record-keeping for regulatory compliance and patient safety.
• Improved laboratory workflow: Streamlined processes and reduced manual errors.
• Data-driven insights: Valuable information for optimizing storage conditions and resource allocation.

 

“We are thrilled with the positive response to our technology at ESHRE 2024,” said Dr. Geoffrey Morris, CEO at Cryogatt. “Our collaboration with the reproductive medicine community is essential in developing solutions that address the evolving needs of the industry. We are committed to providing innovative tools that empower researchers and clinicians to achieve their goals.”

 

Cryogatt is dedicated to partnering with healthcare organizations to optimize their cryogenic storage operations. By leveraging RFID technology, Cryogatt is transforming the way samples are managed, ensuring the highest standards of quality and patient care.